4-(Piperidin-4-yl)morpholine hydrochloride, 95.0%, 10g

1-(4,5-Dichlorothiophen-2-yl)ethanone, 95.0%, 5g

4-(Ethoxymethyl)piperidin-4-ol hydrochloride, 98%, 10g

1-Methyl-1H-benzo[d]imidazol-5-ol, 95.0%, 5g

2-(4-Bromophenyl)-4,4,5,5-tetramethyl-1,3,2-dioxaborolane, 95.0%, 100g

2-bromo-3-methoxy-6-methylpyridine, 95.0%, 1g

1-(4-Hydroxyphenyl)-2-phenylethan-1-one, 98+%, 250mg

Clorhidrato de L-azidolisina, mínimo 98 %, 100 mg, envase de plástico.

Methyl 4-methoxybicyclo[2.2.2]octane-1-carboxylate, 98%, 1g

6-BROMO-3-(BROMOMETHYL)BENZOFURAN, 97.0%, 250mg

6-Sulfamoylnicotinic acid, 98%, 100mg

4-METHOXY-1H,1'H-2,2'-BIPYRROLE-5-CARBALDEHYDE, 95.0%, 250mg

Hexaphenoxycyclotriphosphazene>98.0%(HPLC)(N)25g